Central effects of cromoglycate sodium salt in rats treated with lipopolysaccharide

Citation
F. Nava et Ap. Caputi, Central effects of cromoglycate sodium salt in rats treated with lipopolysaccharide, EUR J PHARM, 367(2-3), 1999, pp. 351-359
Citations number
68
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF PHARMACOLOGY
ISSN journal
00142999 → ACNP
Volume
367
Issue
2-3
Year of publication
1999
Pages
351 - 359
Database
ISI
SICI code
0014-2999(19990219)367:2-3<351:CEOCSS>2.0.ZU;2-S
Abstract
In 24-h water- and food-deprived rats, we have evaluated the effects of cro moglycate sodium salt, an inhibitor of the mast cell degranulation with ant i-inflammatory and membrane-stabilizating activity, on the central effects induced by Escherichia coli lipopolysaccharide (LPS). Intraperitoneal (i.p. ) injection of LPS (0.25, 0.50 and 1 mg/kg) induced a dose-dependent inhibi tion of water and food intake, fever, reduction in locomotor activity as we ll as increased anxiety levels. All these LPS effects were antagonized by a prior intracerebroventricular (i.c.v.) injection of cromoglycate sodium sa lt (100, 150 and 200 mu g/rat). Our findings suggest that peripheral LPS ad ministration may activate brain mast cells and indicate an involvement of t hese cells in brain pathophysiology. (C) 1999 Elsevier Science B.V. All rig hts reserved.